Parkway Life REIT posts higher distributable income despite softer revenue in 1Q26

SGX Filings
04/30

Parkway Life Real Estate Investment Trust (C2PU) reported gross revenue of 38.2 million Singapore dollars for the quarter ended Mar, 31 2026, a 2.1 % decrease from 38.98 million Singapore dollars a year earlier, mainly because of Japanese yen depreciation and the exit of a tenant occupying five nursing homes in Osaka.

Net property income slipped 2.7 % year on year to 35.85 million Singapore dollars, while finance costs rose 7.0 % to 3.53 million Singapore dollars due to capital-expenditure funding and higher yen interest costs. Despite lower revenue, the amount available for distribution rose 15.1 % to 28.82 million Singapore dollars, lifting distribution per unit to 4.42 Singapore cents; the payout will be included in the first-half distribution.

The trust’s leverage remained moderate at 34.2 %, with an interest-coverage ratio of 8.4 times and an all-in debt cost of 1.66 %. No long-term debt matures until Mar, 31 2027. During the quarter the REIT issued a five-year 70.0 million Singapore dollars green bond at 2.103 % per annum and secured a 10-year social loan of 8.8 billion Japanese yen (about 70.9 million Singapore dollars), lengthening its average debt term to about 3.8 years. Approximately 96 % of interest-rate exposure is hedged and income from Japan and Europe is hedged until at least 1Q29 and 1Q30, respectively.

Operationally, the trust completed “Project Renaissance”, a 350 million Singapore dollars renewal of Mount Elizabeth Hospital in Feb, 2026, receiving provisional Green Mark Platinum certification. Meanwhile, the liquidation of tenant Miyako Group affects five Japanese properties but represents only about 1.6 % of projected FY26 gross revenue; security deposits covering four to eight months of rent have been retained.

Minimum rent for the three Singapore hospitals is set to rise to 99.1 million Singapore dollars in FY26, up 24.3 % from FY25, underpinning future income growth.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10